Cefisat-S 350 Tablets combine Cefixime, a broad-spectrum antibiotic, and Sulbactam, a beta-lactamase inhibitor. Each tablet is effective against various bacterial infections, particularly those resistant to other antibiotics. Cefixime kills bacteria by inhibiting cell wall synthesis, while Sulbactam enhances its efficacy by preventing bacterial resistance. Cefisat-S 350 is typically taken as prescribed by a healthcare professional, with or without food, ensuring comprehensive treatment of stubborn infections.Available in PCD pharma franchise and Third Party manufacturing in saturn formulations